IDiyas

For the Inventor, By the Inventor

San Ramon, CA, United States of America

Wooseok Han

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 60(Granted Patents)


Location History:

  • San Ramon, CA (US) (2012 - 2020)
  • Cambridge, MA (US) (2019 - 2022)

Company Filing History:

goldMedal13 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2012-2022

Loading Chart...
Loading Chart...
13 patents (USPTO):
1. 11234977 - Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals (2022-02-01),
2. 10975078 - Fused indazole pyridone compounds as antivirals (2021-04-13),
3. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors (2020-05-26),
4. 10301312 - Fused indazole pyridone compounds as antivirals (2019-05-28),
5. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors (2019-01-29),
6. 9763937 - Aminoheteroaryl benzamides as kinase inhibitors (2017-09-19),
7. 9242996 - Aminoheteroaryl benzamides as kinase inhibitors (2016-01-26),
8. 9079889 - Kinase inhibitors and methods of their use (2015-07-14),
9. 8822497 - PIM kinase inhibitors and methods of their use (2014-09-02),
10. 8748626 - Oxazole and thiazole compounds as KSP inhibitors (2014-06-10),
11. 8592455 - Kinase inhibitors and methods of their use (2013-11-26),
12. 8546434 - Triazole compounds as KSP inhibitors (2013-10-01),
13. 8329732 - Kinase inhibitors and methods of their use (2012-12-11),

Title: The Innovations of Wooseok Han: A Pioneer in Antiviral Compounds

Introduction:

Wooseok Han, a renowned inventor based in San Ramon, CA, has made significant contributions to the field of antiviral compounds. With a total of 13 patents to his name, Han has been instrumental in developing cutting-edge solutions for treating viral infections.

Latest Patents:

1. Fused Tricyclic Pyrazolo-Dihydropyrazinyl-Pyridone Compounds as Antivirals: Han's invention provides compounds of Formula (I) aimed at treating viral infections, particularly those caused by hepatitis B virus (HBV). These compounds have shown promise in reducing the occurrence of serious conditions associated with HBV.

2. Fused Indazole Pyridone Compounds as Antivirals: Another groundbreaking patent by Han, this invention focuses on compounds of Formula (I) for treating viral infections, especially those caused by HBV. The pharmaceutical compositions derived from these compounds offer new avenues for combating HBV-related conditions.

Career Highlights:

Wooseok Han is a key member of the innovative team at Novartis AG, a pharmaceutical company known for its groundbreaking research in healthcare. His expertise and groundbreaking inventions have positioned him as a leader in the development of antiviral solutions.

Collaborations:

Han has collaborated with esteemed professionals in his field, including Keith Bruce Pfister and Yu Ding. Together, they have worked towards advancing the field of antiviral compounds and exploring new treatment possibilities for viral infections.

Conclusion:

In conclusion, Wooseok Han's dedication to innovation and his contributions to the development of antiviral compounds have significantly impacted the medical field. His patents stand as a testament to his commitment to improving healthcare outcomes and combating viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…